We were founded on the belief that a powerful combination of biology and chemistry can unlock the potential of kinase medicines to dramatically improve the lives of patients with genomically defined diseases.
Our discovery engine combines bioinformatics, expertise in structural and cell biology, a proprietary library of novel compounds and world-class drug design capabilities. With these scientific assets, we aim to rapidly identify important disease targets and design transformative precision therapies.